184 related articles for article (PubMed ID: 7505920)
1. Cardioversion, defibrillation, and overdrive pacing of ventricular arrhythmias: the effect of moricizine in dogs with sustained monomorphic ventricular tachycardia.
Avitall B; Hare J; Zander G; Lessila C; Dhala A; Deshpande S; Jazayeri M; Sra J; Akhtar M
Pacing Clin Electrophysiol; 1993 Nov; 16(11):2092-7. PubMed ID: 7505920
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.
Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Kelso D; Mitchell R
Circulation; 1993 Jun; 87(6):1889-96. PubMed ID: 8504501
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
[TBL] [Abstract][Full Text] [Related]
4. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
Siebels J; Schneider MA; Kuck KH
Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological evaluation of moricizine in patients with sustained ventricular tachyarrhythmias: low efficacy and high incidence of proarrhythmia.
Bhandari AK; Lerman R; Ehrlich S; Sager P; Leon C; Widerhorn J; Cannom DS
Pacing Clin Electrophysiol; 1993 Sep; 16(9):1853-61. PubMed ID: 7692418
[TBL] [Abstract][Full Text] [Related]
6. Programmable external automatic antitachycardia pacing as a bridge to definitive therapy in patients with recurrent sustained ventricular tachycardia.
Ahern TS; Nydegger C; Greenspon AJ; Kidwell GA; Hessen SE; McCormick DJ; Kutalek SP
Pacing Clin Electrophysiol; 1992 Sep; 15(9):1258-65. PubMed ID: 1383986
[TBL] [Abstract][Full Text] [Related]
7. Characterization of ventricular fibrillation based on monophasic action potential morphology in the human heart.
Swartz JF; Jones JL; Fletcher RD
Circulation; 1993 Jun; 87(6):1907-14. PubMed ID: 8504503
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
[TBL] [Abstract][Full Text] [Related]
9. Comparison of frequency of aggravation of ventricular tachyarrhythmias after implantation of automatic defibrillators using epicardial versus nonthoracotomy lead systems.
Böcker D; Block M; Isbruch F; Wietholt D; Hammel D; Scheld HH; Borggrefe M; Breithardt G
Am J Cardiol; 1993 May; 71(12):1064-8. PubMed ID: 8475870
[TBL] [Abstract][Full Text] [Related]
10. Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. Multicenter PCD Investigator Group.
Hammill SC; Packer DL; Stanton MS; Fetter J
Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 1):3-10. PubMed ID: 7700828
[TBL] [Abstract][Full Text] [Related]
11. High-current stimuli to the spared epicardium of a large infarct induce ventricular tachycardia.
Kavanagh KM; Kabas JS; Rollins DL; Melnick SB; Smith WM; Ideker RE
Circulation; 1992 Feb; 85(2):680-98. PubMed ID: 1735161
[TBL] [Abstract][Full Text] [Related]
12. The implantable cardioverter defibrillator: technology, indications, and impact on cardiovascular survival.
Bhatia A; Cooley R; Berger M; Blanck Z; Dhala A; Sra J; Axtell-Mcbride K; Vandervort C; Akhtar M
Curr Probl Cardiol; 2004 Jun; 29(6):303-56. PubMed ID: 15159713
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic oral moricizine and intravenous epinephrine on ventricular fibrillation and defibrillation thresholds.
Pharand C; Goldman R; Fan C; Chow M; Kluger J
Pacing Clin Electrophysiol; 1996 Jan; 19(1):82-9. PubMed ID: 8848382
[TBL] [Abstract][Full Text] [Related]
14. Rate-dependent anisotropic conduction property in the epicardial border zone of canine myocardial infarcts and its modification by moricizine.
Tsutsumi N; Mitamura H; Okada Y; Yoshimoto T; Sadanaga T; Furuno I; Ogawa S
Cardiovasc Drugs Ther; 1995 Oct; 9(5):715-22. PubMed ID: 8573555
[TBL] [Abstract][Full Text] [Related]
15. Potential proarrhythmic effect of biventricular pacing: fact or myth?
Shukla G; Chaudhry GM; Orlov M; Hoffmeister P; Haffajee C
Heart Rhythm; 2005 Sep; 2(9):951-6. PubMed ID: 16171749
[TBL] [Abstract][Full Text] [Related]
16. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator.
Chinushi M; Aizawa Y; Higuchi K
Heart; 1997 Apr; 77(4):373-4. PubMed ID: 9155621
[TBL] [Abstract][Full Text] [Related]
17. Implantable transvenous cardioverter-defibrillators.
Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
[TBL] [Abstract][Full Text] [Related]
18. A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails.
Janardhan AH; Li W; Fedorov VV; Yeung M; Wallendorf MJ; Schuessler RB; Efimov IR
J Am Coll Cardiol; 2012 Dec; 60(23):2393-8. PubMed ID: 23141483
[TBL] [Abstract][Full Text] [Related]
19. Entrainment of ventricular tachycardia with a permanent biventricular pacemaker.
Luck JC; Bhatta L; Artman SE; Wolbrette DL; Pantelloni MA; Naccarelli GV
J Interv Card Electrophysiol; 2002 Aug; 7(1):105-11. PubMed ID: 12391427
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and reflex sympathetic control of transmural activation and rate of ventricular tachycardia in ischemic and hypertrophic ventricular myocardium of the dog.
Hopson JR; Martins JB
Circulation; 1992 Aug; 86(2):618-27. PubMed ID: 1353421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
